Search - tctmd.com

Displaying 341 - 360 of 550

Sort: Relevancy | Date

News Daily News

New European Hypertension Guidelines Not in Harmony With US Guidance

Todd Neale

June 11, 2018

News Daily News

Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests

L.A. McKeown

May 23, 2018

News Daily News

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Michael O'Riordan

May 01, 2018

News Daily News

Uncomplicated TLR After PCI Linked With Worse Mortality

Michael O'Riordan

April 20, 2018

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

News Daily News

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Shelley Wood

April 13, 2018

News Daily News

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Michael O'Riordan

April 05, 2018

News Daily News

Unplanned Readmissions Within 30 Days Post-PCI Affect Nearly One in 10 US Patients

L.A. McKeown

April 04, 2018

News Daily News

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

Yael L. Maxwell

March 30, 2018

News Daily News

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Shelley Wood

March 29, 2018

News Daily News

Less Aggressive HbA1c Targets Recommended by American College of Physicians

Michael O'Riordan

March 06, 2018

News Daily News

Multivessel PCI Improves Outcomes in STEMI Patients With Cardiogenic Shock: Korean Registry

Caitlin E. Cox

February 23, 2018

News Daily News

ICD Benefit Questioned in Patients With Chronic Kidney Disease

Todd Neale

February 09, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

One-Third of TAVR and SAVR Patients Are Depressed, Upping Mortality Risk

L.A. McKeown

January 18, 2018

STEMI Patients With Multivessel Disease Best Served by a Single Procedure: Meta-analysis

News Daily News

STEMI Patients With Multivessel Disease Best Served by a Single, Complete Procedure: Meta-analysis

Caitlin E. Cox

December 15, 2017

News Daily News

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Caitlin E. Cox

December 13, 2017

News Daily News

Some Concerns About New ‘Tour de Force’ Hypertension Guidelines

Todd Neale

December 04, 2017

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Caitlin E. Cox

November 30, 2017

News Daily News

Nephroprotective NOACs? Renal Dysfunction Not Infrequent Among A-fib Patients, but Some Agents Reduce Risk

Yael L. Maxwell

November 28, 2017

Advertisement

New European Hypertension Guidelines Not in Harmony With US Guidance

Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Uncomplicated TLR After PCI Linked With Worse Mortality

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Unplanned Readmissions Within 30 Days Post-PCI Affect Nearly One in 10 US Patients

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Less Aggressive HbA1c Targets Recommended by American College of Physicians

Multivessel PCI Improves Outcomes in STEMI Patients With Cardiogenic Shock: Korean Registry

ICD Benefit Questioned in Patients With Chronic Kidney Disease

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

One-Third of TAVR and SAVR Patients Are Depressed, Upping Mortality Risk

STEMI Patients With Multivessel Disease Best Served by a Single, Complete Procedure: Meta-analysis

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Some Concerns About New ‘Tour de Force’ Hypertension Guidelines

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Nephroprotective NOACs? Renal Dysfunction Not Infrequent Among A-fib Patients, but Some Agents Reduce Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content